Persistent URL of this record https://hdl.handle.net/1887/117202
Documents
-
- Download
- Lancet_Infect_Dis_2016_16_685
- Not Applicable (or Unknown)
-
open access
In Collections
This item can be found in the following collections:
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
- All authors
- Manns, M.; Samuel, D.; Gane, E.J.; Mutimer, D.; McCaughan, G.; Buti, M.; Prieto, M.; Calleja, J.L.; Peck-Radosavljevic, M.; Mullhaupt, B.; Agarwal, K.; Angus, P.; Yoshida, E.M.; Colombo, M.; Rizzetto, M.; Dvory-Sobol, H.; Denning, J.; Arterburn, S.; Pang, P.S.; Brainard, D.; McHutchison, J.G.; Dufour, J.F.; Vlierberghe, H. van; Hoek, B. van; Forns, X.; SOLAR-2 Investigators
- Date
- 2016-06-01
- Journal
- The Lancet Infectious Diseases
- Volume
- 16
- Issue
- 6
- Pages
- 685 - 697